Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
WHO GMP certified manufacturing
Product Description
Molnupiravir was originally developed to treat influenza at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory